Skip to main content

Advertisement

Articles

Page 3 of 6

  1. Content type: Research

    The rising demand for chronic disease treatment and the barriers to accessing these medicines have led to the development of novel models for distributing medicines in South Africa’s public sector, including d...

    Authors: Bvudzai Priscilla Magadzire, Bruno Marchal and Kim Ward

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:28

    Published on:

  2. Content type: Review

    Worldwide the demands on emergency and primary health care services are increasing. General practitioners and accident and emergency departments are often used unnecessarily for the treatment of minor ailments...

    Authors: Louise E. Curley, Janice Moody, Rukshar Gobarani, Trudi Aspden, Maree Jensen, Maureen McDonald, John Shaw and Janie Sheridan

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:29

    Published on:

  3. Content type: Research

    Medicines are a main therapeutic intervention provided within hospitals and their proper use in the outpatient setting is important for patients and the community. The objective of this study was to evaluate d...

    Authors: Muhammad Atif, Muhammad Rehan Sarwar, Muhammad Azeem, Danial Umer, Abdul Rauf, Arslan Rasool, Muhammad Ahsan and Shane Scahill

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:27

    Published on:

  4. Content type: Review

    The United States (U.S.) Food and Drug Administration, as protectors of public health, encourages generic drug development and use so that patients can access affordable medications. The FDA, however, has limi...

    Authors: Chia-Ying Lee, Xiaohan Chen, Robert J. Romanelli and Jodi B. Segal

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:26

    Published on:

  5. Content type: Commentary

    The proposed Pharmacy Bill of Malaysia which served to consolidate and harmonise the existing pharmacy legislation which has been used for more than 60 years. This new Pharmacy Bill contains 17 parts and a tot...

    Authors: Kah Seng Lee, Yen Wei Lim and Long Chiau Ming

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:25

    Published on:

  6. Content type: Research

    Providing patient-centred care requires pharmacy students to learn how to interact effectively and understand individual differences that can influence patients’ health. The School of Pharmacy at The University o...

    Authors: Louise E. Curley, Maureen McDonald and Trudi Aspden

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:24

    Published on:

  7. Content type: Research

    Lack of access to insulin and poor health outcomes are issues for both low and high income countries. This has been accompanied by a shift from relatively inexpensive human insulin to its more expensive analog...

    Authors: Warren A. Kaplan and Reed F. Beall

    Citation: Journal of Pharmaceutical Policy and Practice 2016 10:3

    Published on:

  8. Content type: Research

    Pharmacists in Japan currently play a key role in patient hospital care. Their responsibilities include filling prescriptions, checking a patient’s medication history, and providing appropriate information to ...

    Authors: Daiki Yasunaga, Yuichi Tasaka, Satoshi Murakami, Akihiro Tanaka, Mamoru Tanaka and Hiroaki Araki

    Citation: Journal of Pharmaceutical Policy and Practice 2016 10:2

    Published on:

  9. Content type: Research

    Due to the lack of clear, comprehensive, and rational drug policy, the production of pharmaceutical preparations in India is distorted for the most part. Indian markets are flooded with more than 70,000 formul...

    Authors: Anandhasayanam Aravamuthan, Mohanavalli Arputhavanan, Kannan Subramaniam and Sam Johnson Udaya Chander J

    Citation: Journal of Pharmaceutical Policy and Practice 2016 10:1

    Published on:

  10. Content type: Research

    The Integrated Management of Childhood Illnesses is the main approach for treating children in more than 100 low income countries worldwide. In 2007, the World Health Assembly urged countries to integrate ‘bet...

    Authors: Xavier Nsabagasani, Japer Ogwal-Okeng, Ebba Holme Hansen, Anthony Mbonye, Herbert Muyinda and Freddie Ssengooba

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:22

    Published on:

  11. Content type: Research

    Uganda introduced a multipronged intervention, the supervision, performance assessment, and recognition strategy (SPARS), to improve medicines management (MM) in public and not-for-profit health facilities. Th...

    Authors: Birna Trap, Denis Okidi Ladwar, Martin Olowo Oteba, Martha Embrey, Mohammed Khalid and Anita Katharina Wagner

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:21

    Published on:

  12. Content type: Research

    In 2014, a qualitative multi-country research project was launched to study the reasons behind the high use of antibiotics in regions of Southeast Europe by using previously untrained national interviewers (wh...

    Authors: Susanne Kaae, Sofia Kälvemark Sporrong, Janine Morgall Traulsen, Helle Wallach Kildemoes, Lotte Stig Nørgaard, Arianit Jakupi, Denis Raka, Emre Umut Gürpinar, Ali Alkan, Iris Hoxha, Admir Malaj and Lourdes Arevalo Cantarero

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:20

    Published on:

  13. Content type: Editorial

    This editorial introduces a series of case studies that together highlight the use of health market interventions to improve access to medicines in low-and-middle income countries (LMICs). It underscores the a...

    Authors: Zubin Shroff, Maryam Bigdeli, Zaheer-Ud-Din Babar, Anita Wagner, Abdul Ghaffar and David H Peters

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:19

    Published on:

  14. Content type: Research

    Since its inception, the Uganda National Drug Authority (NDA) has regularly inspected private sector pharmacies to monitor adherence to Good Pharmacy Practices (GPP). This study reports findings from the first...

    Authors: Birna Trap, Kate Kikule, Catherine Vialle-Valentin, Richard Musoke, Grace Otto Lajul, Kim Hoppenworth and Dorthe Konradsen

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:18

    Published on:

  15. Content type: Research

    India shoulders the greatest global burden of cardiovascular diseases (CVDs), which are the leading cause of mortality worldwide. Drugs are the bedrock of treatment and prevention of CVD. India’s pharmaceutica...

    Authors: Charles Newman, Vamadevan S. Ajay, Ravi Srinivas, Sandeep Bhalla, Dorairaj Prabhakaran and Amitava Banerjee

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:16

    Published on:

  16. Content type: Letter to the Editor

    Exorbitant price increases for critical off-patent medicines have received considerable media attention in recent months, leading to an investigation by the U.S. Senate. However, much of this attention has foc...

    Authors: Adam R. Houston, Reed F. Beall and Amir Attaran

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:15

    Published on:

  17. Content type: Research

    Consumers are hesitant in choosing generic medications as they are under the assumption that they are not as safe nor effective as brand medications. However, pharmacists do have the education and training to ...

    Authors: Mira Patel, Marion Slack, Janet Cooley and Sandipan Bhattacharjee

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:17

    Published on:

  18. Content type: Commentary

    Achieving increased access to medicines in low- and middle-income countries is a complex issue that requires a holistic approach. Choosing an appropriate manufacturing strategy that can ensure a sustainable su...

    Authors: Mutsumi Metzler and Patricia S. Coffey

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:14

    Published on:

  19. Content type: Commentary

    Despite the high level of spending on cancer medicines in Australia, consumer organisations and the pharmaceutical industry often make claims of delayed or lack of access to new cancer medicines—claims that ar...

    Authors: Agnes Vitry, Barbara Mintzes and Wendy Lipworth

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:13

    Published on:

  20. Content type: Research

    Many patients even those with health insurance pay out-of-pocket for medicines. We investigated the availability and prices of essential medicines in the Boston area.

    Authors: Abhishek Sharma, Lindsey Rorden, Margaret Ewen and Richard Laing

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:12

    Published on:

  21. Content type: Research

    A wide range of pharmaceutical products are needed for diagnosis, treatment, and prevention of HIV/AIDS. However, interrupted supplies and stock-outs are the major challenges in the supply chain of ARV medicin...

    Authors: Eyerusalem Berhanemeskel, Gebremedhin Beedemariam and Teferi Gedif Fenta

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:11

    Published on:

  22. Content type: Research

    Antibiotic resistance is a serious global public health problem directly correlated to high antibiotic consumption. Romania is one of the European countries with the highest rates of antibiotic consumption, no...

    Authors: I. Ghiga and C. Stålsby Lundborg

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:10

    Published on:

  23. Content type: Editorial

    In October 2015, the third international Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference was held in Vienna to foster discussion on challenges in pricing and reimbursement policies for m...

    Authors: Sabine Vogler, Nina Zimmermann, Alessandra Ferrario, Veronika J. Wirtz, Kees de Joncheere, Hanne Bak Pedersen, Guillaume Dedet, Valérie Paris, Aukje K. Mantel-Teeuwisse and Zaheer-Ud-Din Babar

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:9

    Published on:

  24. Content type: Research

    Financial recession mandated the introduction of harsh austerity measures. Health, and particularly pharmaceuticals, constitute a significant part of public expenditure and as such they have been subject to si...

    Authors: Panagiotis Petrou and Michael A. Talias

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:8

    Published on:

  25. Content type: Research

    Clinical pharmacy service has evolved steadily over the past few decades and is contributing to the ‘patient care journey’ at all stages. The service improves safety and effectiveness of medicines, thereby avo...

    Authors: Arebu Issa Bilal, Zelalem Tilahun, Gebremedhin Beedemariam, Belete Ayalneh, Bisrat Hailemeskel and Ephrem Engidawork

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:7

    Published on:

  26. Content type: Research

    Ghana established its National Health Insurance Scheme (NHIS) in 2003 with the goal of ensuring more equitable financing of health care to improve access to health services. This qualitative study examines the...

    Authors: Paul G. Ashigbie, Devine Azameti and Veronika J. Wirtz

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:6

    Published on:

  27. Content type: Research

    Clinical trials showed a higher risk of skin- and liver- related adverse reactions when NVP-based antiretroviral therapy (ART) was initiated in female and male patients with baseline CD4 cell counts ≥250 and ≥...

    Authors: Francis Kalemeera, Assegid T. Mengistu and Johannes Gaeseb

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:5

    Published on:

  28. Content type: Research

    Little is known about the perceived attitude, barriers and facilitators of Saudi Pharmacists about practice based research. We aimed to measure the attitude, barriers, and facilitators of Saudi hospital pharma...

    Authors: Khizra Sultana, Majed Al Jeraisy, Maha Al Ammari, Rahul Patel and Syed Tabish R. Zaidi

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:4

    Published on:

  29. Content type: Research

    This scoping review investigates the relationship between governance, pharmacovigilance, and Agencia Nacional de Vigilancia Sanitaria (ANVISA) in Brazil, which has authority over Brazil's national pharmaceutic...

    Authors: Kathy Moscou, Jillian C. Kohler and Anita MaGahan

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:3

    Published on:

  30. Content type: Research

    As medicines are becoming more targeted and complex in the U.S., ensuring patients’ safe use of medications with known dangerous risks is critical for public health and safety. Therefore, the Risk Evaluation a...

    Authors: Stacey L. Worthy

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:2

    Published on:

  31. Content type: Research

    The increasing prevalence of chronic diseases puts a high burden on the health care systems of Low and Middle Income Countries which are often not adapted to provide the care needed. Peer support programmes ar...

    Authors: Josefien van Olmen, Natalie Eggermont, Maurits van Pelt, Heang Hen, Jeroen de Man, François Schellevis, David H. Peters and Maryam Bigdeli

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:1

    Published on:

  32. Content type: Erratum

    Authors: Edmund Rutta, Jafary Liana, Martha Embrey, Keith Johnson, Suleiman Kimatta, Richard Valimba, Rachel Lieber, Elizabeth Shekalaghe and Hiiti Sillo

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:29

    Published on:

    The original article was published in Journal of Pharmaceutical Policy and Practice 2015 8:23

  33. Content type: Research

    The Nigerian health sector battles with control of infectious diseases and emerging non-communicable diseases. Number of healthcare personnel involved in public health programs need to be boosted to contain th...

    Authors: Ogochukwu Offu, Maureen Anetoh, Matthew Okonta and Obinna Ekwunife

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:27

    Published on:

  34. Content type: Research

    The irrational use of reserved antimicrobials, such as ceftriaxone, is one of the global public health issues particularly to low income countries like Ethiopia, leading to high costs of treatment or therapeut...

    Authors: Tariku Shimels, Arebu I Bilal and Anwar Mulugeta

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:26

    Published on:

  35. Content type: Review

    Some humanitarian and development organizations respond to major natural disasters and emergencies by donating medicines. Many provide medicines on a routine basis to support health systems, particularly those...

    Authors: Nuria Cañigueral-Vila, Jennifer C. Chen, Lindsey Frenkel-Rorden and Richard Laing

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:28

    Published on:

  36. Content type: Research

    Withdrawal of conditional regulatory approval or subsidization of new medicines when subsequent evidence does not confirm early trial results may not be well understood or accepted by the public.

    Authors: Agnes Vitry, Tuan Nguyen, Vikky Entwistle and Elizabeth Roughead

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:25

    Published on:

  37. Content type: Review

    Hypertension is the leading modifiable cause of mortality worldwide. Unlike many conditions where limited evidence exists for management of older individuals, multiple large, robust trials have provided a soli...

    Authors: Tariq M Alhawassi, Ines Krass and Lisa G Pont

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:24

    Published on:

Annual Journal Metrics

Advertisement